Natural history of cervical intraepithelial neoplasia: A meta-analysis

Acta Cytologica

Volumn 49, Issue 4, 2005, Pages 405-415

  Cantor, Scott B ^a,c   Atkinson, E Neely ^a   Cardenas Turanzas, Marylou ^a   Benedet, J L ^b   Follen, Michele ^c   MacAulay, Calum ^d  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Cervical intraepithelial neoplasia; Cervical neoplasms; Mass screening; Meta analysis

Indexed keywords

CANCER GRADING; CANCER RISK; FEMALE; HUMAN; HUMAN TISSUE; META ANALYSIS; PRECANCER; PRIORITY JOURNAL; PROBABILITY; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

EID: 22444448698     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326174     Document Type: Review

References (50)

1. Kurman RJ, Henson DE, Herbst AL, Nouer KL, Schiffman MH: Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-1869
2. Ries L, Kosary C, Hankey B, Miller B, Edwards B: SEER Cancer Statistics Review, 1973-1995. Bethesda, National Cancer Institute, 1998
3. Myers E, McCrory D, Subramanian S, McCall N, Nanda K, Datta S, Matcher D: Setting the target for a better cervical screening test: Characteristics of a cost-effective test for cervical neoplasia screening. Obstet Gynecol 2000;96:645-652
4. Braly PS, Lichter AS, Ash DK, Bader JL: NIH Consensus Statement Online, 1996
5. Sedlacek TV, Cooper AS: Cervical cancer screening: What is cost-effectiveness? J Lower Gen Tract Dis (suppl 1) 1999;3:S1-S7
6. Schlechter C: Cost-effectiveness of rescreening conventionally prepared cervical smears by PAPNET testing. Acta Cytol 1996; 40:1272-1282
7. Nyirjesy I: Atypical or suspicious cervical smears: An aggressive diagnostic approach. JAMA 1972;222:691-693
8. Richart RM: Cervical intraepithelial neoplasia. Pathol Annu 1973;8:301-328
9. Reagan JW, Fu YS: Histologie types and prognosis of cancers of the uterine cervix. Int J Radiat Oncol Biol Phys 1979;5:1015-1020
10. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: Revised after the second National Cancer Institute Workshop, April 29-30, 1991. Acta Cytol 1993;37:115-125
11. McCrory D, Matchar D: Evaluation of Cervical Cytology. Rockville, Maryland, Agency for Health Care Policy and Research, US Department of Health and Human Services, 1999
12. Shiffman M, Herrero R, Hildesheim A, Sherman M, Bratti M, Wacholder S, Alfaro M, Hutchinson M, Morales J, Greenberg MD, Lorincz AT: HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica. JAMA 2000;283:87-93
13. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M: Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-474
14. Miller D, Hamon S: Determining transition probabilities: Confusion and suggestions. Med Decis Making 1994;14:52-58
15. Chambers J, Cleveland W, Kleiner B, Tukey P: Graphical Methods for Data Analysis. Pacific Grove, California, Wadsworth and Brooks/Cole, 1983
16. Lee SS, Collins RJ, Pun TC, Cheng DK, Ngan HY: Conservative treatment of low grade squamous intraepithelial lesions (LSIL) of the cervix. Intl J Gynecol Obstet 1998;60:35-40
17. Brown M, Phillips G: Management of the mildly abnormal Pap smear: A conservative approach. Gynecol Oncol 1985;22:149-153
18. Boyes DA, Morrison B, Knox EG, Draper GJ, Miller AB: A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 1982;5:1-21
19. Masterson J: An analysis of untreated intra-epithelial carcinoma of the cervix. Proc of Third National Cancer Conference, Detroit, 1956. Philadelphia, JB Lippincott, 1957, pp 671-673
20. Hollowaty F, Miller A, Rohan T, To T: Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-258
21. Melnikow J, Nuovo J, Willan A, Chan B, Howell L: Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obstet Gynecol 1998;92:727-735
22. Sawaya G, Kerlikowske K, Lee N, Gildengorin G, Washington A: Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol 2000;96:219-223
23. Melnikow J, Nuovo J, Paliescheskey M: Management choices for patients with "squamous atypia" on Papanicolaou smear: A toss up? Med Care 1996;34:336-347
24. Kim J, Wright T, Goldie S: Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-2390
25. Mandelblatt J, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, Gold K, Barter J, Shah K: Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002; 287:2372-2381
26. Cantor S, Fahs M, Mandelblatt J, Myers E, Sanders G: Decision science and cervical cancer. Cancer 2003;98:2003-2008
27. Fox C: Biologic behavior of dysplasia and carcinoma in situ. Am J Obstet Gynecol 1967;99:960-974
28. Nasiell K, Nasiell M, Vaclavinkova V, Roger V, Hjerpe A: Follow-up studies of cytologically detected precancerous lesions (dysplasia) of the uterine cervix. In Health Control in Detection of Cancer. Skandia International Symposia, September 23-25, 1975. Edited by H Boston, T Larsson, N Ljungstedt. Stockholm, Almquist & Wiksell, 1976
29. Kolstad P, Klem V: Long-term follow-up of 1121 cases of carcinoma in situ. Obstet Gynecol 1976;48:125-129
30. Gad C: The management and natural history of severe dysplasia and carcinoma in situ of the uterine cervix. Br J Obstet Gynaecol 1976;83:554-559
31. Fu Y, Reagan J, Richart R: Definition of precursors. Gynecol Oncol 1981;12:220-231
32. Westgaard L, Norgaard M: Severe cervical dysplasia: Control by biopsies or primary conization? A comparative study. Acta Obstet Gynecol Scand 1981;60:549-554
33. Nasiell K, Nasiell M, Vaclavinkova V: Behaviour of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 1983;61:609-614
34. McIndoe W, McLean M, Jones R, Mullins P: The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol 1984; 64:451-58
35. Luthra UK, Prabhakar AK, Seth P, Agarwal SS, Murthy NS, Bhatnagar P, Das DK, Sharma BK: Natural history of precancerous and early cancerous lesions of the uterine cervix. Acta Cytol 1987;31:226-234
36. Mitchell H, Drake M, Medley G: Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection. Lancet 1986;1:573-575
37. Paraskevadis E, Kalantaridou SN, Georgiou I, Koliopoulos G, Pappa L, Malamou-Mitsi V, Agnantis NJ, Kitchener HC, Lolis DE: Spontaneous evolution of human papillomavirus infection in the uterine cervix. Anticancer Research 1999;19:3473-3478
38. Jones MH, Jenkins D, Cuzick J, Wolfendale MR, Jones JJ, Balogura-Lynch C, Usherwood MM, Singer A: Mild cervical dyskaryosis: Safety of cytological surveillance. Lancet 1992;339: 1440-1443
39. Nasiell K, Roger V, Nasiell M: Behaviour of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67: 665-669
40. Bibbo M, Dytch H, Alenghat E, Bartels P, Wied G: DNA ploidy profiles as prognostic indicators in CIN lesions. Am J Clin Pathol 1989;92:261-265
41. Montz F, Monk B, Fowler J, Nguyen L: Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 1992;80:385-388
42. Mikhail M, Merkatz J, Romney S: Clinical usefulness of computerized colposcopy: Image analysis and conservative management of mild dysplasia. Obstet Gynecol 1992;80:5-8
43. Lindgren J, Vesterinen E, Purola E, Wahlstrom T: Prognostic significance of tissue carcinoembryonic antigen in mild dysplasia of the uterine cervix. Tumour Biol 1985:465-470
44. Flannelly G, Anderson D, Kitchener HC, Mann EM, Campbell M, Fisher P, Walker F, Templeton AA: Management of women with mild and moderate cervical dyskaryosis. Br Med J 1994;308:1399-1403
45. Campion M, McCance D, Cuzick S: Progessive potential of mild cervical atypia: Prospective cytological, colposcopic, and virological study. Lancet 1986;2:237-240
46. Murthy M, Sardana S, Narang N, Agarwal S, Sharma S, Das D: Biological behaviour of moderate dysplasia: A prospective study. Indian J Cancer 1996;33:24-30
47. Syrjanen K, Mantyjarvi R, Varymen M, Syrjanen S, Yliskoski M, Saarikoski S, Castren O: Evolution of human papillomavirus infections in the uterine cervix during a long-term prospective follow-up. Appl Pathol Microbiol Scand (suppl) 1960;243:36-40
48. Heatley M: Follow-up of women with borderline cervical smears as defined by national guidelines. J Clin Pathol 1999;52: 787-788
49. Robertson J, Woodend B, Crozier E, Hutchinson J: Risk of cervical cancer associated with mild dyskaryosis. Br Med J 1988; 297:18-21
50. Weaver M, Abdul-Karim F, Dale G, Sorensen K, Huang Y: Outcome in mild and moderate cervical dysplasias related to the presence of specific human papillomavirus types. Mod Pathol 1990;3:679-683